Skip to main content
Back to Wellington Management

Wellington Management's Medical Portfolio

Browse 42 Medical companies funded by Wellington Management. See funding amounts, founder contacts, and investment details.

Medical Companies
42
Total Funding in Medical
$8.0B

Medical Portfolio Companies (42)

Export
Health CareMedicalPharmaceutical

Judi Health is a healthtech platform that provides pharmacy benefit management solutions.

New York, United States
September 2025
$252.0M
Series F

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical DevicePharmaceutical

RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.

San Diego, United States
September 2022
$160.0M
Series D

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalNeurosciencePharmaceuticalTherapeutics

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

Waltham, United States
September 2025
$150.0M
Series A

Founder Contacts

30,000+ verified contacts

Health CareInformation TechnologyMedicalmHealthTelehealth

Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs.

Los Angeles, United States
July 2022
$20.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareHealth DiagnosticsMedical DeviceOncology

Strata Oncology is a precision oncology company dedicated to transforming cancer care.

Ann Arbor, United States
July 2021
$90.0M
Series C

Founder Contacts

30,000+ verified contacts

BioinformaticsBiotechnologyHealth CareMedical

Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.

Cambridge, United States
June 2022
$1.3B
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedical

Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.

Cambridge, United States
June 2023
$75.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

RQ Bio is a biotechnology company that develops medicine based on potent broad-spectrum mAbs to provide immunity to viral infections.

London, United Kingdom
June 2026
$112.5M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyEmergency MedicineGeneticsHealth CareMedical

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

Boston, United States
June 2024
$100.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Cambridge, United States
June 2026
$200.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics

Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.

Cambridge, United States
June 2026
$50.0M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedicalOncology

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

Philadelphia, United States
May 2025
$40.2M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalTherapeutics

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

San Mateo, United States
May 2024
$110.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.

San Francisco, United States
May 2026
$1.3B
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

Health CareMedicalTherapeuticsWellness

Omada Health is a digital behavioral medicine company that helps members change their mindsets to improve health and build lasting change.

San Francisco, United States
May 2025
Secondary Market

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMedical

Heartflow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.

Mountain View, United States
March 2025
$98.0M
Convertible Note

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceMedicalTherapeutics

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Stevenage, United Kingdom
March 2022
$26.1M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalTherapeutics

Chroma Medicine is a biotechnology company that develops genetic medicines for the treatment of genetic disorders.

Cambridge, United States
February 2023
$135.0M
Series B

Founder Contacts

30,000+ verified contacts

Health CareHealth DiagnosticsHospitalMedicalPrimary and Urgent CareWellness

Somatus is a healthcare company that partners with health plans, health systems, nephrology, and primary care groups.

Mclean, United States
February 2022
$325.0M
Series E

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

Seattle, United States
July 2025
$100.0M
Series D

Founder Contacts

30,000+ verified contacts

HardwareManufacturingMedical DeviceSoftware

Lumafield develops industrial computed tomography (CT) solutions for non-destructive testing and inspection for engineers.

Cambridge, United States
March 2025
$75.0M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalTherapeutics

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

San Mateo, United States
January 2025
$65.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalMedical DevicePharmaceutical

Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.

Cambridge, United States
June 2023
$150.0M
Series B

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)ElectronicsHealth CareManufacturingMedical DeviceSemiconductor

Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.

Burlington, United States
January 2025
$75.6M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical DeviceTherapeutics

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.

Rockville, United States
December 2025
$185.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth DiagnosticsMedicalTherapeutics

SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.

South San Francisco, United States
December 2024
$100.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsMedicalTherapeutics

GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.

South San Francisco, United States
December 2021
$300.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Cambridge, United States
December 2025
$602.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyDiabetesMedical Device

Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.

Irvine, United States
November 2024
$60.0M
Series E

Founder Contacts

30,000+ verified contacts

BiopharmaHealth CareMedicalPharmaceutical

Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.

New York, United States
November 2024
$215.0M
Series B

Founder Contacts

30,000+ verified contacts

Health CareMedicalMedical DeviceNeuroscienceTherapeutics

Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.

Bloomington, United States
November 2025
$30.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.

Waltham, United States
November 2025
$200.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyClinical TrialsHealth CareMedicalPharmaceuticalTherapeutics

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Hayward, United States
October 2025
$250.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

Watertown, United States
October 2025
$225.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CareMedicalPharmaceutical

Tricida operates in the healthcare industry focusing on pharmaceutical business.

Menlo Park, United States
October 2022
$125.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

Westlake Village, United States
February 2026
$130.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalProduct Research

nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.

Boston, United States
December 2024
$75.0M
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.

Suzhou, China
August 2023
$100.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalOncology

NiKang Therapeutics is a biotech company focused on discovering and developing small molecule oncology medicines.

Wilmington, United States
May 2021
$200.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedical

Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders.

Solana Beach, United States
January 2021
$125.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical Device

PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.

Redwood City, United States
August 2020
$70.0M
Series D

Founder Contacts

30,000+ verified contacts

BioinformaticsBiotechnologyHealth CareMedicalTherapeutics

NEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer.

Cambridge, United States
December 2017
$36.0M
Series B

Founder Contacts

30,000+ verified contacts

Explore Wellington Management's Full Portfolio

View all companies funded by Wellington Management across every industry and funding stage.

View Full Wellington Management Portfolio